33ADC
Biological
Seattle Genetics, Inc.
Total Payments
$2.2M
Transactions
363
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $2.2M | 363 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.2M | 359 | 99.5% |
| Consulting Fee | $9,948 | 4 | 0.5% |
Payments by Type
Research
$2.2M
359 transactions
General
$9,948
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SG0CD33A0005 | Seattle Genetics, Inc. | $1.3M | 0 |
| SG0CD33A0002 | Seattle Genetics, Inc. | $641,332 | 0 |
| SG0CD33A0001 | Seattle Genetics, Inc. | $134,825 | 0 |
| SG0CD33A0003 | Seattle Genetics, Inc. | $87,541 | 0 |
| SG0CD33A0006 | Seattle Genetics, Inc. | $30,675 | 0 |
| SG0CD33A0007 | Seattle Genetics, Inc. | $5,720 | 0 |
Ad
Manufacturing Companies
- Seattle Genetics, Inc. $2.2M
Product Information
- Type Biological
- Total Payments $2.2M
- Total Doctors 3
- Transactions 363
About 33ADC
33ADC is a biological associated with $2.2M in payments to 3 healthcare providers, recorded across 363 transactions in the CMS Open Payments database. The primary manufacturer is Seattle Genetics, Inc..
Payment data is available from 2017 to 2017. In 2017, $2.2M was paid across 363 transactions to 3 doctors.
The most common payment nature for 33ADC is "Unspecified" ($2.2M, 99.5% of total).
33ADC is associated with 6 research studies, including "SG0CD33A0005" ($1.3M).